Apeiron Therapeutics

Apeiron Therapeutics intends to develop breakthrough investigational medicines by harnessing the power of artificial intelligence which drastically increases efficiency throughout the drug discovery process, from target selection, hit identification, lead optimization to pre-clinical studies and clinical trials. GT Apeiron is strategically based in Shanghai and in the San Francisco Bay Area, with significant collaborations in the UK enabling us to tap into technologies and talent from all three continents

Apeiron therapeutics operates in the Biotechnology research industry.

Apeiron therapeutics's revenue is 11m - 100m

Apeiron therapeutics has 11 - 50 employees.